to reduce the cost of active pharmaceutical ingredient for new TB drugs especially for diarylquinoline class molecules. This will improve the access of new TB drugs and decrease TB disease burden particularly for low and mid-income countrie
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
